Treatment type: Immunotherapies
-
T cells open the door to potential immune therapies
Keeping T cells active, but not too active, could be the key to new potential immune therapies, according to the latest research.… Read more
-
Endometriosis research in focus on the airwaves
Hudson Institute’s endometriosis research was in focus on Melbourne radio over the weekend, as long-running science program Einstein A-Go-Go devoted its whole hour to the disease.… Read more
-
Searching for clues to how RNA triggers the immune system
A young Melbourne scientist will spend the next three years advancing exiting new mRNA research to unlock the secrets to how RNA triggers the immune system to fight infection.… Read more
-
Hudson Institute welcomes childhood cancer pledge
As a global leader in the field of childhood cancer research, Hudson Institute of Medical Research welcomes the Victorian Government’s pledge to invest $35 million in this area of vital need.… Read more
-
Big step toward slowing emphysema
Researchers are closer than ever to being able to turn off the actions of the immune system that damage the lungs – opening up the possibility of slowing emphysema development.… Read more
-
US Defense Dept backs Aussie upper gastrointestinal cancer research
If an army marches on its stomach, as the old saying goes, then the US Department of Defense (DoD) is investing wisely in Australian upper gastrointestinal cancer research.… Read more
-
Victorian government funding boost for new anti-inflammatory treatments
Hudson Institute’s groundbreaking research into new anti-inflammatory treatments has attracted the support of the Victorian government, in recognition of its potential to treat COVID-19 and other infectious diseases.… Read more
-
RNA boost for autoimmune disease
The enormous potential of RNA-based treatments for autoimmune diseases has been recognised by the Victorian government, with a new grant from the mRNA Victoria Research Acceleration Fund.… Read more
-
Flicking the inflammation off-switch
Many human diseases, including autoimmune diseases such as arthritis or inflammatory bowel disease, are characterised by too much inflammation.
There has been a gap in producing new generations of potent anti-inflammatory therapeutics for these anti-inflammatory conditions.… Read more -
Lachy’s story: hope against Stage IV neuroblastoma
At 18 months, Lachy developed fevers, vomiting and general tiredness. Doctors thought it was a daycare virus and he would get over it. Lachy had an 11 cm tumour in his abdomen and was diagnosed with Stage IV neuroblastoma, which had spread to his bone marrow.… Read more